↓ Skip to main content

Integrase inhibitors: Why do we need a new drug class for HIV therapy?

Overview of attention for article published in European Journal of Medical Research, November 2009
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Integrase inhibitors: Why do we need a new drug class for HIV therapy?
Published in
European Journal of Medical Research, November 2009
DOI 10.1186/2047-783x-14-s3-1
Pubmed ID
Authors

Jürgen Kurt Rockstroh

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 36%
Student > Bachelor 3 27%
Other 1 9%
Student > Ph. D. Student 1 9%
Researcher 1 9%
Other 0 0%
Unknown 1 9%
Readers by discipline Count As %
Medicine and Dentistry 4 36%
Biochemistry, Genetics and Molecular Biology 3 27%
Immunology and Microbiology 2 18%
Agricultural and Biological Sciences 1 9%
Unknown 1 9%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2018.
All research outputs
#8,537,346
of 25,377,790 outputs
Outputs from European Journal of Medical Research
#230
of 923 outputs
Outputs of similar age
#51,637
of 177,888 outputs
Outputs of similar age from European Journal of Medical Research
#4
of 16 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 923 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,888 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.